GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Retail - Defensive » X Bioscience PCL (BKK:XBIO-W7) » Definitions » Research & Development

X Bioscience PCL (BKK:XBIO-W7) Research & Development : ฿0.0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2025. Start your Free Trial

What is X Bioscience PCL Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. X Bioscience PCL's Research & Development for the three months ended in Mar. 2025 was ฿0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was ฿0.0 Mil.

X Bioscience PCL Research & Development Historical Data

The historical data trend for X Bioscience PCL's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

X Bioscience PCL Research & Development Chart

X Bioscience PCL Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

X Bioscience PCL Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

X Bioscience PCL Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

X Bioscience PCL  (BKK:XBIO-W7) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

X Bioscience PCL Research & Development Related Terms

Thank you for viewing the detailed overview of X Bioscience PCL's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

X Bioscience PCL Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Retail - Defensive » X Bioscience PCL (BKK:XBIO-W7) » Definitions » Research & Development
Comparable Companies
BKK:KK SYY USFD XLIS:JMT PFGC LSE:BNZL JSE:BID BKK:CPAXT ASX:MTS SGX:VC2 CHEF HAM:B4B XKRX:026960 ADX:GHITHA TSE:7451 SZSE:000061 WAR:KER UNFI XKRX:006040 ANDE
Traded in Other Exchanges
XBIO:Thailand
Address
Phahon Yothin Road, No.304, Room No.1803-1806, 18th Floor, Vanit Place Aree Tower (Tower A, Sam Sen Nai, Bangkok, THA, 10400
Website
https://www.xbio.co.th
X Bioscience PCL is engaged in investment in food and beverages business and the group are engaged in selling food and beverages, and manufacturing and selling biological products. The group operates in two business segments: the food and beverage sales segment and the internal management services segment provided by the parent company. The group operates in a single geographic area, which is Thailand. The company's brand consists of Kagonaya, Bake, and Leboeuf.

X Bioscience PCL Headlines

No Headlines